Latest DEF 14A proxy statements

Neuphoria Therapeutics Inc. announced a strategic review to maximize stockholder value, confirming an unsolicited non-binding acquisition offer of $5.20 per share from Lynx1 Master Fund LP and director nominations.

Integrated Wellness Acquisition Corp (IWAC) announces an amended business combination agreement to merge with Btab Ecommerce Group, Inc., valuing Btab at $250 million, with plans for a Nasdaq listing for the combined entity.

Workhorse Group Inc. details its Q3 2025 financial results, strategic merger with Motiv Power Systems, and future product roadmap.

Oculus Inc. has filed definitive additional materials related to its proxy statement with the SEC.

Crescent Energy Company has agreed to acquire Vital Energy, Inc. through an all-stock merger, with Vital stockholders receiving 1.9062 shares of Crescent Class A Common Stock for each Vital share.

Cannae Holdings reports significant progress on its strategic plan in Q3 2025, focusing on portfolio rebalancing, capital returns, and operational improvements, highlighted by substantial share buybacks and a strategic shift towards sports assets.

Air Lease Corporation announced the expiration of the Hart-Scott-Rodino waiting period, a significant step towards its merger with Sumisho Air Lease Corporation.

Avidity Biosciences announces its acquisition by Novartis for approximately $12 billion, plans a spin-off of its early-stage precision cardiology programs, and reports strong Q3 2025 financial results with positive clinical data.

Workhorse Group reported third-quarter 2025 financial results, including a reduced net loss, and provided updates on its proposed merger with Motiv Electric Trucks.

Lee Enterprises announced its intent to pursue an equity rights offering of up to $50 million, aiming to reduce its term loan interest rate from 9% to 5% for five years.

Premier, Inc. reminds stockholders to vote FOR the proposed merger with Patient Square Capital at the upcoming Special Meeting on November 21, 2025, emphasizing the Board's unanimous recommendation.

Co-Diagnostics, Inc. will hold a Special Meeting on December 5, 2025, to seek shareholder approval for a reverse stock split to maintain its Nasdaq listing.

TEGNA Inc. filed supplemental disclosures to its definitive proxy statement to address shareholder lawsuits alleging misleading information regarding its merger with Nexstar Media Group.

Investcorp Credit Management BDC, Inc. announced its 2025 Annual Meeting of Stockholders to be held on December 18, 2025, primarily for the election of one director.

Applied DNA Sciences calls a Special Meeting to approve warrant exercises, increase authorized shares, and expand its equity incentive plan to support its new BNB digital asset strategy.

Anteris Technologies Global Corp. announces its 2025 Annual Meeting of Stockholders to address director elections, auditor ratification, and significant RSU grants for executives and non-employee directors.

CISO Global, Inc. is seeking stockholder approval for significant equity plan expansion, a $15 million preferred stock issuance to B. Riley, and a substantial increase in authorized common stock.

Forge Global Holdings, Inc. announced a definitive merger agreement to become a wholly-owned subsidiary of The Charles Schwab Corporation.

Theriva Biologics, Inc. is holding a Special Meeting to approve the issuance of up to 16.18 million common shares from new warrant exercises, a condition for potential capital.

Hologic, Inc. issued an internal FAQ to employees detailing the impact of its acquisition by Blackstone and TPG on benefits, bonuses, and equity awards.

Jaguar Health, Inc. calls a Special Meeting to approve the issuance of common stock related to Series N Preferred Stock exchanges and a new PIPE financing, crucial for Nasdaq compliance.

Zymeworks Inc. announced its Annual Meeting of Stockholders for December 30, 2025, to address director elections, executive compensation, and auditor ratification.

Gulf Island Fabrication, Inc. has entered into a definitive merger agreement to be acquired by IES Holdings, Inc. for $12.00 per share in cash.

Zymeworks Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 30, 2025, focusing on director elections, executive compensation, and auditor ratification, alongside reporting 2024 financial and operational highlights.

Cracker Barrel Old Country Store, Inc. defends its multi-year strategic plan and board nominees against an activist shareholder, highlighting FY2205 financial gains and operational adjustments.

Paramount Group's Board of Directors unanimously recommends stockholders approve a cash merger with Rithm Capital Corp. at $6.60 per share, offering a significant premium and immediate liquidity.

Brilliant Earth Group, Inc. is reincorporating from Delaware to Nevada, a move approved by its board and majority stockholders, citing a desire for greater legal predictability and stability.

TEN Holdings, Inc. is pursuing a reverse stock split, ranging from 1-for-10 to 1-for-20, to address its Nasdaq minimum bid price deficiency and maintain its listing.

Revelation Biosciences, Inc. calls a Special Meeting to approve the issuance of common stock exceeding Nasdaq's 20% cap, crucial for funding and continued listing.

Onconetix, Inc. calls for its Annual Meeting to approve significant private placement financings, elect new directors, and ratify its independent auditor.